Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
13
×
life sciences
biotech
boston blog main
boston top stories
national
san diego blog main
san diego top stories
san francisco blog main
new york blog main
new york top stories
san francisco top stories
clinical trials
startups
fda
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
bristol-myers squibb
cancer
eli lilly
genomics
investing
nonalcoholic steatohepatitis
pfizer
What
biotech
13
×
new
drug
medicines
roundup
bio
days
news
raised
research
annual
attention
based
biologics
cancer
company
control
diseases
drugs
genomics
investment
ipo
life
medicine
million
podcast
precision
san
startup
therapeutics
today
turned
week
abcellera
abcellera’s
according
ahead
aiming
aims
akcea
Language
unset
Current search:
biotech
×
" national top stories "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Explore San Diego’s Precision Medicine and Genomics Sector in Xconomy’s New Podcast and Special Report
@xconomy.com
4 years ago
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
CPRIT Grants, TMC & Baird, Shipt & Drive.ai Expand, & More TX Tech
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More